Myeloid Cells: Functional Heterogeneity with Therapeutic Promise

This Keystone Myeloid Cell meeting aims to bring together key leaders in academia and industry to discuss recent insights regarding myeloid cell functional heterogeneity and how to target these cells for therapeutic interventions. It is clear that myeloid cells hold significant therapeutic promise, but this potential is yet to be realized. While previous meetings have typically focused on academic advances, this meeting will also cover the latest industry approaches and novel therapeutic applications. By bringing together all actors we will stimulate discussions and collaboration that will drive translational advances and more rapidly realize transformative applications in the field.